TRK-IN-12

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

TRK-IN-12 

TRK-IN-12 (Compound 9e) 是一种有效的 TRK 抑制剂 (TRKG595R IC50 = 13.1 nM)。TRK-IN-12 是一种大环衍生化合物。TRK-IN-12 在 Ba/F3-LMNA-NTRK1 细胞系中显示出显着的抗增殖活性 (IC50 = 0.080 μM)。TRK-IN-12 在 Ba/F3-LMNA-NTRK1-G595R 细胞系中显示出比对照药物 LOXO-101 更好的抑制作用 (IC50 = 0.646 μM)。

TRK-IN-12

TRK-IN-12 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

TRK-IN-12 (Compound 9e) is a potent inhibitor of TRK (TRKG595R IC50 = 13.1 nM). TRK-IN-12 is a macrocyclic derivative compound. TRK-IN-12 shows significant antiproliferative activity in the Ba/F3-LMNA-NTRK1 cell line (IC50 = 0.080 μM). TRK-IN-12 has shown a better inhibitory effect (IC50 = 0.646 μM) than control drug LOXO-101 in Ba/F3-LMNA-NTRK1-G595R cell line[1].

分子量

439.89

Formula

C18H19ClFN5O3S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Li P, et al. Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors [published correction appears in Bioorg Med Chem Lett. 2022 Jan 15;56:128502]. Bioorg Med Chem Lett. 2021;53:128409.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务